This elevated energy burn can translate into quicker and more efficient fat loss
Subcutaneous Oxyntomodulin Reduces Body Weight in Overweight and Obese Subjects: A Double-Blind, Randomized, Controlled Trial
Patients who switched from tirzepatide to orforglipron maintained a mean 74.7% of their body weight reduction from the SURMOUNT-5 trial compared with those in the placebo group, which maintained a mean 49.2% of their weight loss
It also drives fat out of storage and into the bloodstream to be used as fuel, and produces significant liver fat reduction
~ AlphaMD You started testosterone replacement therapy to feel like yourself again, but now your joints ache, your libido is gone, and your mood is worse than before you ever touched a needle
Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IB alpha induction and block of NFB and iNOS activation